Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,209,777 papers from all fields of science
Search
Sign In
Create Free Account
Aspirin / Dipyridamole
Known as:
Aspirin Dipyridamole Drug Combination
, Combination, Aspirin-Dipyridamole Drug
, ASPIRIN/DIPYRIDAMOLE
Expand
A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule
Aspirin
Dipyridamole
In Blood
Expand
Narrower (3)
Aggrenox
Asasantin
Asasantin Retard
Broader (1)
Platelet Aggregation Inhibitors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Antithrombotic treatment for peripheral arterial disease
D. Hackam
,
J. Eikelboom
Heart
2006
Corpus ID: 27448802
Context: Patients with peripheral arterial disease (PAD) bear a substantial risk for vascular events in the coronary, cerebral…
Expand
2005
2005
Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial
B. Dixon
,
G. Beck
,
+13 authors
H. Feldman
Clinical Trials
2005
Corpus ID: 46004212
Background Surgically created arteriovenous (AV) grafts are the most common type of hemodialysis vascular access in the United…
Expand
Review
2003
Review
2003
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
S. Connolly
American Heart Journal
2003
Corpus ID: 1967518
Atrial fibrillation (AF) is common, and it increases the risk of stroke. Placebo-controlled trials consistently showed that…
Expand
Review
2000
Review
2000
Antiplatelet agents in stroke prevention. combination therapy: present and future.
B. Weksler
Cerebrovascular Diseases
2000
Corpus ID: 29727144
Platelets contribute to arterial thrombosis by multiple mechanisms that promote blood clotting, favor vasoconstriction, activate…
Expand
Review
1999
Review
1999
Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit–risk analysis
G. Boysen
Journal of Internal Medicine
1999
Corpus ID: 20594043
Abstract. Boysen G (University of Copenhagen, Copenhagen, Denmark). Bleeding complications in secondary stroke prevention by…
Expand
Highly Cited
1986
Highly Cited
1986
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
M. Verstraete
,
B. Brown
,
+6 authors
P. Sleight
European Heart Journal
1986
Corpus ID: 21039287
The cumulative occlusion rates of aorto-coronary artery venous bypass grafts average from 16 to 26% per distal anastomosis within…
Expand
1986
1986
Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
S. Heptinstall
,
S. Fox
,
J. Crawford
,
M. Hawkins
Thrombosis Research
1986
Corpus ID: 7328969
1983
1983
Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prostheses and quantitation of visceral microembolism in dogs.
M. Dewanjee
,
V. Fuster
,
S. A. Rao
,
P. Forshaw
,
M. Kaye
Mayo Clinic proceedings
1983
Corpus ID: 41815514
A noninvasive technique has been developed in the dog model for imaging, with a gamma camera, the platelet deposition on Björk…
Expand
Highly Cited
1981
Highly Cited
1981
Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
M. Josa
,
J. Lie
,
R. Bianco
,
M. Kaye
American Journal of Cardiology
1981
Corpus ID: 7413582
Highly Cited
1979
Highly Cited
1979
Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.
W. Hollander
,
B. Kirkpatrick
,
J. Paddock
,
M. Colombo
,
S. Nagraj
,
S. Prusty
Experimental and molecular pathology (Print)
1979
Corpus ID: 23973041
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE